More evidence suggests type 2 diabetes is an inflammatory disease

As people's waistlines increase, so does the incidence of type 2 diabetes. Now scientists have a better understanding of exactly what happens in the body that leads up to type 2 diabetes, and what likely causes some of the complications related to the disease. Specifically, scientists from Denmark have found that in mice, macrophages, a specific type of immune cell, invade the diabetic pancreatic tissue during the early stages of the disease. Then, these inflammatory cells produce a large amount of pro-inflammatory proteins, called cytokines, which directly contribute to the elimination of insulin-producing beta cells in the pancreas, resulting in diabetes. This discovery was published in the January 2014 issue of the Journal of Leukocyte Biology.

"The study may provide novel insights allowing development of tailor-made anti-inflammatory based therapies reducing the burden of type 2 patients," said Alexander Rosendahl, Ph.D., a researcher involved in the work from the Department of Diabetes Complication Biology at Novo Nordisk A/S, in Malov, Denmark. "These novel treatments may prove to complement existing therapies such as insulin and GLP-1 analogues."

To make their discovery scientists compared that spontaneously developed diabetes to healthy mice. The mice were followed from a young age when the obese mice only showed early diabetes, to an age where they displayed systemic complication in multiple organs. Presence of macrophages around the in the pancreas and in the spleen was evaluated by state-of-the-art flow cytometric technology allowing evaluation on a single cell level. At both the early and late stages, the showed significant modulations compared to healthy mice.

"The more researchers learn about obesity and , the more it appears that inflammation plays a critical role in the progression and severity of these conditions," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "This study sheds light on how a key inflammatory cell is connected to disease and what might go wrong when someone has type 2 . The knowledge gained from such studies offers hope that new immune-based therapies could be developed to mitigate the severity of such dieseases."

More information: J. Leukoc. Biol. January 2014 95:149-160; DOI: 10.1189/jlb.0213075

Related Stories

Researchers prevent mice from developing diabetes

Jun 29, 2012

(Medical Xpress) -- Swedish research group headed at Karolinska Institutet has been able to prevent onset of Type 1 diabetes in mice that are genetically susceptible to the disease. Through injection of specifically ...

Endocannabinoids trigger inflammation that leads to diabetes

Aug 20, 2013

(Medical Xpress)—Researchers at the National Institutes of Health have clarified in rodent and test tube experiments the role that inflammation plays in type 2 diabetes, and revealed a possible molecular target for treating ...

Recommended for you

Gamers helping in Ebola research

9 hours ago

Months before the recent Ebola outbreak erupted in Western Africa, killing more than a thousand people, scientists at the University of Washington's Institute for Protein Design were looking for a way to stop the deadly virus.

Carcinogenic role of a protein in liver decoded

11 hours ago

The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study ...

A new way to diagnose malaria, using magnetic fields

Aug 31, 2014

Over the past several decades, malaria diagnosis has changed very little. After taking a blood sample from a patient, a technician smears the blood across a glass slide, stains it with a special dye, and ...

User comments